menu
    • menu

    Company profile for VectorY

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide. Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene th...
    VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide. Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a special focus on muscle diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VectorYNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Science Park Matrix Innovation Center 408 1098 XH Amsterdam
    Telephone
    Telephone
    +31(0)202268020
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vectorytx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vectorytx1/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VectorY Bets $1.2 B+ on Shape's Brain-Penetrant Capsids
    VectorY Bets $1.2 B+ on Shape's Brain-Penetrant Capsids

    19 Sep 2025

    // BIOSPACE

    https://www.biospace.com/business/vectory-bets-up-to-1-2b-that-shapes-brain-penetrant-capsids-are-a-fit

    BIOSPACE
    19 Sep 2025
    Share Share
    Vector Y Names Jessica Atkinson Chief Business Officer
    Vector Y Names Jessica Atkinson Chief Business Officer

    27 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250527171431/en/VectorY-Therapeutics-Appoints-Jessica-Atkinson-as-Chief-Business-Officer

    BUSINESSWIRE
    27 May 2025
    Share Share
    VectorY Therapeutics to Present ALS Data at Target ALS Conference
    VectorY Therapeutics to Present ALS Data at Target ALS Conference

    07 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250507576427/en/VectorY-Therapeutics-to-Present-Preclinical-Data-on-Novel-ALS-Therapeutic-Strategy-at-Target-ALS-Conference-in-Boston

    BUSINESSWIRE
    07 May 2025
    Share Share
    VectorY Therapeutics to Present at ASGCT 2025
    VectorY Therapeutics to Present at ASGCT 2025

    29 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250429558932/en/VectorY-Therapeutics-Announces-Multiple-Presentations-at-Upcoming-American-Society-of-Gene-and-Cell-Therapy-Annual-Meeting-2025

    BUSINESSWIRE
    29 Apr 2025
    Share Share
    VectorY Appoints Jim Scibetta as New CEO
    VectorY Appoints Jim Scibetta as New CEO

    16 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241216441837/en

    BUSINESSWIRE
    16 Dec 2024
    Share Share
    UMC Utrecht And VectorY Collaborate In ALS Biomarker Study
    UMC Utrecht And VectorY Collaborate In ALS Biomarker Study

    17 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240617705597/en

    BUSINESSWIRE
    17 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search